Timely Antiviral Administration During an Influenza Pandemic

Key Components

Bibliographic Data

ID11026850
AuthorsLisa M Koonin (0000-0002-9132-5331, Both authors are with the Influenza Coordination Unit, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA.), Anita Patel (0000-0003-0769-1732, Both authors are with the Influenza Coordination Unit, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA.)
Year2018
Volume108
IssueS3
PagesS215-S220
Publication date2018-09-01
Open AccessNo
TypeARTICLE
VenueAmerican Journal of Public Health (JOURNAL)
Journal identifiersISSN: 0090-0036 • E-ISSN: 1541-0048
PublisherAmerican Public Health Association (PUBLISHER • US)
DOI10.2105/ajph.2018.304609
PMID30192657
OpenAlexW2891535435
LanguageEN
References cited20

Prompt treatment of ill persons with influenza antivirals will be an important part of a future pandemic influenza response. This essay reviews key lessons learned from the 2009 H1N1 pandemic and the changing landscape of antiviral drug availability, and identifies and describes the multiple components needed to ensure the timely administration of antiviral drugs during a future pandemic. Fortunately, many of these planning efforts can take place before a pandemic strikes to improve outcomes during a future public health emergency

2019-20 coronavirus outbreak · Administration (probate law) · Antiviral drug · Antiviral treatment · Computer security · Coronavirus disease 2019 (COVID-19) · Disease · H1N1 influenza · H1n1 pandemic · Infectious disease (medical specialty) · Influenza pandemic · Intensive care medicine · Key (lock) · Medical emergency · Pandemic · Pandemic influenza · Political science · Public health · Virus · Computer Science · Influenza Virus Research Studies · Law · Medicine · Nursing · Respiratory viral infections research · Viral Infections and Outbreaks Research · Virology

Tools

Open DOISci-HubOpen Access